Inhibition of phospholipase A-induced swelling of mitochondria by local anesthetics and related agents.
D010129:4-Aminobenzoic Acid / Q000008:administration & dosage / Q000494:pharmacology; D000588:Amines / Q000494:pharmacology; D000779:Anesthetics, Local / Q000494:pharmacology*; D000818:Animals; D002746:Chlorpromazine / Q000008:administration & dosage / Q000494:pharmacology; D003992:Dibucaine / Q000008:administration & dosage / Q000494:pharmacology; D005227:Fatty Acids / Q000494:pharmacology; D005230:Fatty Acids, Nonesterified / Q000096:biosynthesis; D007700:Kinetics; D008244:Lysophosphatidylcholines / Q000096:biosynthesis; D008928:Mitochondria / Q000187:drug effects*; D008933:Mitochondrial Swelling / Q000187:drug effects; D010740:Phospholipases / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D011398:Promethazine / Q000008:administration & dosage / Q000494:pharmacology; D011433:Propranolol / Q000008:administration & dosage / Q000494:pharmacology; D051381:Rats; D012911:Snakes; D013095:Spermidine / Q000494:pharmacology; D013096:Spermine / Q000494:pharmacology; D013997:Time Factors; D014688:Venoms
D000588:Amines; D000779:Anesthetics, Local; D005227:Fatty Acids; D005230:Fatty Acids, Nonesterified; D008244:Lysophosphatidylcholines; D014688:Venoms; D013096:Spermine; D011433:Propranolol; D010740:Phospholipases; D011398:Promethazine; D003992:Dibucaine; D010129:4-Aminobenzoic Acid; D002746:Chlorpromazine; D013095:Spermidine